The data shown below were collected from the profiles of 597 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis.
|
|---|---|
| Published in |
JAMA Internal Medicine, December 2018
|
| DOI | 10.1001/jamainternmed.2018.4710 |
| Pubmed ID | |
| Authors |
Bruno Kovic, Xuejing Jin, Sean Alexander Kennedy, Mathieu Hylands, Michal Pedziwiatr, Akira Kuriyama, Huda Gomaa, Yung Lee, Morihiro Katsura, Masafumi Tada, Brian Y Hong, Sung Min Cho, Patrick Jiho Hong, Ashley M Yu, Yasmin Sivji, Augustin Toma, Li Xie, Ludwig Tsoi, Marcin Waligora, Manya Prasad, Neera Bhatnagar, Lehana Thabane, Michael Brundage, Gordon Guyatt, Feng Xie |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 56 | 9% |
| Spain | 33 | 6% |
| United Kingdom | 23 | 4% |
| Australia | 13 | 2% |
| Canada | 12 | 2% |
| France | 8 | 1% |
| Brazil | 7 | 1% |
| Denmark | 6 | 1% |
| Switzerland | 5 | <1% |
| Other | 55 | 9% |
| Unknown | 379 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 355 | 59% |
| Scientists | 122 | 20% |
| Practitioners (doctors, other healthcare professionals) | 105 | 18% |
| Science communicators (journalists, bloggers, editors) | 12 | 2% |
| Unknown | 3 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 134 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 134 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 13% |
| Student > Master | 14 | 10% |
| Other | 12 | 9% |
| Student > Bachelor | 11 | 8% |
| Student > Ph. D. Student | 9 | 7% |
| Other | 16 | 12% |
| Unknown | 55 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 30% |
| Nursing and Health Professions | 7 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Agricultural and Biological Sciences | 3 | 2% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Other | 11 | 8% |
| Unknown | 63 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 546. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 June 2023.
All research outputs
#47,835
of 26,565,554 outputs
Outputs from JAMA Internal Medicine
#409
of 11,899 outputs
Outputs of similar age
#859
of 451,549 outputs
Outputs of similar age from JAMA Internal Medicine
#11
of 125 outputs
Altmetric has tracked 26,565,554 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,899 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 86.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,549 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.